Stocks
Agios Pharmaceuticals (AGIO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.14 | 1.73 | 3.52 | 2.66 | 1.83 | -1.34 | |||
| Changes by years, y/y, % | -49% | +52% | +103% | -25% | -31% | -3.8% | |||
Agios Pharmaceuticals. Debt/EBITDA
Agios Pharmaceuticals. Debt/EBITDA, changes, %
Agios Pharmaceuticals (AGIO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.57 | 1.81 | 1.36 | 1.27 | -1.34 | -1.34 | ||
| Changes by years, y/y, % | -6% | +35% | -26% | -27% | -186% | |||
| Changes by quarters, q/q, % | -9% | +16% | -25% | -7% | -206% | |||
